2 results match your criteria: "NIPRO Corporation Pharmaceutical Research Center[Affiliation]"
Int J Pharm
October 2013
NIPRO Corporation Pharmaceutical Research Center, Kusatsu, Japan.
Objective: We obtained improvement of erythritol compactibility by formulating composite particles composed of erythritol and porous silica using a twin-screw kneader.
Methods: Erythritol-based tablets formulated with composite particles were directly compacted, and we estimated their hardness and the friability. The compression properties of the erythritol powder bed including composite particles were estimated using a Heckel analysis and force-displacement profiles, and we investigated the physical states of the composite particles by powder X-ray diffractometry, a thermal analysis and a nitrogen gas adsorption study.
Objective: Solventless dry powder coating methods have many advantages compared to solvent-based methods: they are more economical, simpler, safer, more environmentally friendly and easier to scale up. The purpose of this study was to investigate a highly effective dry powder coating method using the mechanofusion system, a mechanochemical treatment equipped with high compressive and shearing force.
Materials And Methods: Acetaminophen (AAP) and carnauba wax (CW) were selected as core particles of the model drug and coating material, respectively.